Congress must reauthorize a committee to support older Americans

OlderadultsandfirstresponderswaitinlinetoreceiveaCovid-19vaccineattheLakesRegionalLibraryinDecember2 AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real




hotspot

author：fashion    Page View：493
Franklin faces
Adobe

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

advertisement

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Delta passengers in Vegas fall sick while waiting on flight in triple
Next article： After affirmative action ruling, medical educators look to 'holistic review'